Point-of-care applications held the largest size of the biosensors market in 2016
POC applications can be segmented into glucose monitoring, cardiac markers, infectious diseases, coagulation monitoring, pregnancy and fertility testing, blood gas and electrolytes, tumor or cancers markers, urinalysis testing, and cholesterol tests, and others. Cardiac markers are the most dynamic POC applications and are expected to witness several innovations and investments over the next five years, owing to the increasing number of people suffering from cardiovascular diseases (CVDs) and rising demand for instant diagnosis of these diseases. Glucose monitoring to hold the largest share of the biosensors market for point-of-care applications by 2022
Blood glucose monitoring plays a crucial role in the management of diabetes. Glucose biosensors provide real-time information on the changes in glucose concentration. The glucose biosensors technology helps individuals maintain normal blood glucose levels. The rising prevalence of diabetes worldwide, technological advancements in self-monitoring of blood glucose, and growing awareness about POC testing are the key factors boosting the demand for glucose monitoring biosensors. Among all the applications, glucose monitoring held the largest size of the biosensors in 2016. The increasing number of people suffering from diabetes among the urban population is boosting the demand for glucose monitoring biosensors.
According to MarketsandMarkets the industry in APAC is expected to grow at a high rate between 2017 and 2022. The increasing number of people suffering from diabetes and government initiatives toward the improvement of the healthcare sector in the region are boosting the demand for glucose monitors, in which biosensors are used, in APAC.
